rHuEPO

基本解释

CINC-1 may play a negative role in the secondary SCI. rHuEPO reduces the expression of CINC-1mRNA in the injured spinal cord,has neuroprotective effect in the secondary SCI.
CINC-1参与继发性脊髓损伤过程,rHuEPO抑制脊髓损伤后CINC-1mRNA的表达,对脊髓继发性损伤可能有保护作用。
HPLC/ESI/MS peptide mapping is a powerful tool for the analysis of rHuEPO. rHuEPO was digested with Glu-C and separated by microbore HPLC, and analyzed by online ESI/CID/MS. All the peptides and glycopeptides except a tripeptide were identified.
本文采用谷氨酸内切酶(Glu-C)将rHuEPO所有糖基化位点酶解成含糖肽段，HPLC/ESI/MS肽图谱分析，并通过源内碰撞诱导解离（In-source CID）分析了氨基酸序列。
Maintenance dose of rHuEPO in dialysis patients
透析病人重组人红细胞生成素的维持用量
rHuEpo is effective in treating MTA.
Epo治疗MTA有效
recombinant human erythmpoietin (rHuEPO)
人重组促红细胞生成素